Medicine and Dentistry
Programmed Cell Death
100%
Imatinib
100%
Chronic Myelogenous Leukemia
85%
K562 Cells
42%
Leukemia Cell
42%
Promoter Region
28%
Tyrosine-Kinase Inhibitor
28%
Globin
28%
Protein Expression
14%
Immune Response
14%
Protein Tyrosine Kinase
14%
Serositis
14%
Lymphocyte
14%
Oncogene
14%
Microarray Analysis
14%
Real-Time Polymerase Chain Reaction
14%
Glycophorin A
14%
Chronic Myeloid Leukemia Cell Line
14%
Biochemistry, Genetics and Molecular Biology
CD24
100%
Imatinib
100%
CD69
100%
Myeloid
53%
K562 Cells
23%
Promoter Region
15%
Messenger RNA
15%
Tyrosine Kinase Inhibitor
15%
Globin
15%
Protein Expression
7%
Microarrays
7%
Lymphocyte
7%
Tyrosine Kinase
7%
Oncogene
7%
Real-Time Polymerase Chain Reaction
7%
CD34
7%
Glycophorin
7%
Receptor Tyrosine Kinase
7%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Myeloid Leukemia
100%
Imatinib
100%
Protein Tyrosine Kinase Inhibitor
28%
Globin
28%
Protein Tyrosine Kinase
14%
Glycophorin A
14%
Inflammation
14%
Immunology and Microbiology
CD69
100%
Myeloid
46%
Leukemia Cell
23%
Promoter Region
15%
Globin
15%
Protein Expression
7%
Lymphocyte
7%
Inflammation Response
7%
Oncogene
7%
Real-Time Polymerase Chain Reaction
7%
CD34
7%
Chronic Myeloid Leukemia Cell Line
7%